. 2019 Apr 8;12(4):371–378. doi: 10.1111/cts.12622
© 2019 Amgen Inc. and Swedish Orphan Biovitrum. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.